| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2164057 | Trends in Cancer | 2016 | 4 Pages |
Abstract
Recent molecular characterization of prostate cancer (PCa) identified novel genetic aberrations and disease subtypes. The frequencies of molecular aberrations show racial disparity. Clinical strategies and targeted therapies embracing these racial differences are required. Here we discuss ethnic differences in genetic alterations and their impact on the susceptibility, progression, and treatment of prostate cancer.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Bushra Ateeq, Vipul Bhatia, Sakshi Goel,